Vaccine-induced plasmablast responses in rhesus macaques: Phenotypic characterization and a source for generating antigen-specific monoclonal antibodies

Journal of Immunological Methods

Volumn 416, Issue , 2015, Pages 69-83

  Silveira, Eduardo L V ^a,b   Kasturi, Sudhir P ^b   Kovalenkov, Yevgeniy ^a   Rasheed, Ata Ur ^b   Yeiser, Patryce ^a   Jinnah, Zarpheen S ^b   Legere, Traci H ^b   Pulendran, Bali ^a,b   Villinger, Francois ^a,b   Wrammert, Jens ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Macaque plasmablasts; Monoclonal antibodies; Phenotype; Sorting

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 140; MONOCLONAL ANTIBODY; ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY ISOLATION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CELL SELECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; MEMORY CELL; MULTIGENE FAMILY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMA CELL; PLASMABLAST; PRIORITY JOURNAL; RHESUS MONKEY; VACCINATION; ANIMAL; ANIMAL MODEL; B LYMPHOCYTE; CELL SEPARATION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PROCEDURES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALIA; MACACA; MACACA MULATTA;

AIDS VACCINES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENS; B-LYMPHOCYTES; CELL SEPARATION; ENZYME-LINKED IMMUNOSPOT ASSAY; HIV; HIV INFECTIONS; IMMUNOLOGIC MEMORY; MACACA MULATTA; MODELS, ANIMAL; PLASMA CELLS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES;

EID: 84922152110     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.11.003     Document Type: Article

References (65)

1. (U.S.), I.o.l.a.r. Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, D.C. 7th ed.
2. Balakrishnan T., Bela-Ong D.B., Toh Y.X., Flamand M., Devi S., Koh M.B., Hibberd M.L., Ooi E.E., Low J.G., Leo Y.S., Gu F., Fink K. Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS One 2011, 6:e29430.
3. Band V.I., Ibegbu C., Kaur S.P., Cagle S.M., Trible R., Jones C.L., Wang Y.F., Kraft C.S., Ray S.M., Wrammert J., Weiss D.S. Induction of human plasmablasts during infection with antibiotic-resistant nosocomial bacteria. J. Antimicrob. Chemother. 2014, 69:1830.
4. Barille S., Thabard W., Robillard N., Moreau P., Pineau D., Harousseau J.L., Bataille R., Amiot M. CD130 rather than CD126 expression is associated with disease activity in multiple myeloma. Br. J. Haematol. 1999, 106:532.
5. Barouch D.H., Whitney J.B., Moldt B., Klein F., Oliveira T.Y., Liu J., Stephenson K.E., Chang H.W., Shekhar K., Gupta S., Nkolola J.P., Seaman M.S., Smith K.M., Borducchi E.N., Cabral C., Smith J.Y., Blackmore S., Sanisetty S., Perry J.R., Beck M., Lewis M.G., Rinaldi W., Chakraborty A.K., Poignard P., Nussenzweig M.C., Burton D.R. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 2013, 503:224.
6. Blanchard-Rohner G., Pulickal A.S., Jol-van der Zijde C.M., Snape M.D., Pollard A.J. Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood 2009, 114:4998.
7. Brochet X., Lefranc M.P., Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008, 36:W503.
8. Burton D.R., Ahmed R., Barouch D.H., Butera S.T., Crotty S., Godzik A., Kaufmann D.E., McElrath M.J., Nussenzweig M.C., Pulendran B., Scanlan C.N., Schief W.R., Silvestri G., Streeck H., Walker B.D., Walker L.M., Ward A.B., Wilson I.A., Wyatt R. A blueprint for HIV vaccine discovery. Cell Host Microbe 2012, 12:396.
9. Chevrier S., Genton C., Kallies A., Karnowski A., Otten L.A., Malissen B., Malissen M., Botto M., Corcoran L.M., Nutt S.L., Acha-Orbea H. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3895.
10. Demberg T., Brocca-Cofano E., Xiao P., Venzon D., Vargas-Inchaustegui D., Lee E.M., Kalisz I., Kalyanaraman V.S., Dipasquale J., McKinnon K., Robert-Guroff M. Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques. J. Virol. 2012, 86:12591.
11. Demberg T., Mohanram V., Venzon D., Robert-Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin. Immunol. 2014, 153:264.
12. Doria-Rose N.A., Klein R.M., Manion M.M., O'Dell S., Phogat A., Chakrabarti B., Hallahan C.W., Migueles S.A., Wrammert J., Ahmed R., Nason M., Wyatt R.T., Mascola J.R., Connors M. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J. Virol. 2009, 83:188.
13. Doria-Rose N.A., Schramm C.A., Gorman J., Moore P.L., Bhiman J.N., DeKosky B.J., Ernandes M.J., Georgiev I.S., Kim H.J., Pancera M., Staupe R.P., Altae-Tran H.R., Bailer R.T., Crooks E.T., Cupo A., Druz A., Garrett N.J., Hoi K.H., Kong R., Louder M.K., Longo N.S., McKee K., Nonyane M., O'Dell S., Roark R.S., Rudicell R.S., Schmidt S.D., Sheward D.J., Soto C., Wibmer C.K., Yang Y., Zhang Z., Mullikin J.C., Binley J.M., Sanders R.W., Wilson I.A., Moore J.P., Ward A.B., Georgiou G., Williamson C., Abdool Karim S.S., Morris L., Kwong P.D., Shapiro L., Mascola J.R., Becker J., Benjamin B., Blakesley R., Bouffard G., Brooks S., Coleman H., Dekhtyar M., Gregory M., Guan X., Gupta J., Han J., Hargrove A., Ho S.L., Johnson T., Legaspi R., Lovett S., Maduro Q., Masiello C., Maskeri B., McDowell J., Montemayor C., Mullikin J., Park M., Riebow N., Schandler K., Schmidt B., Sison C., Stantripop M., Thomas J., Thomas P., Vemulapalli M., Young A. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 2014, 509:55.
14. Drach J., Gattringer C., Glassl H., Drach D., Huber H. The biological and clinical significance of the KI-67 growth fraction in multiple myeloma. Hematol. Oncol. 1992, 10:125.
15. Fera D., Schmidt A.G., Haynes B.F., Gao F., Liao H.X., Kepler T.B., Harrison S.C. Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:10275.
16. Franz B., May K.F., Dranoff G., Wucherpfennig K. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood 2011, 118:348.
17. Giudicelli V., Brochet X., Lefranc M.P. IMGT/V-QUEST: IMGT standarized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb. Protoc. 2011, 2011:695.
18. Gonzalez-Garcia I., Ocana E., Jimenez-Gomez G., Campos-Caro A., Brieva J.A. Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J. Immunol. 2006, 176:4042.
19. Good-Jacobson K.L., Song E., Anderson S., Sharpe A.H., Shlomchik M.J. CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. J. Immunol. 2012, 188:4217.
20. Gujer C., Sundling C., Seder R.A., Karlsson Hedestam G.B., Lore K. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Immunology 2011, 134:257.
21. Hansen S.G., Piatak M., Ventura A.B., Hughes C.M., Gilbride R.M., Ford J.C., Oswald K., Shoemaker R., Li Y., Lewis M.S., Gilliam A.N., Xu G., Whizin N., Burwitz B.J., Planer S.L., Turner J.M., Legasse A.W., Axthelm M.K., Nelson J.A., Fruh K., Sacha J.B., Estes J.D., Keele B.F., Edlefsen P.T., Lifson J.D., Picker L.J. Immune clearance of highly pathogenic SIV infection. Nature 2013, 502:100.
22. Haynes B.F., Kelsoe G., Harrison S.C., Kepler T.B. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat. Biotechnol. 2012, 30:423.
23. Hessell A.J., Poignard P., Hunter M., Hangartner L., Tehrani D.M., Bleeker W.K., Parren P.W., Marx P.A., Burton D.R. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat. Med. 2009, 15:951.
24. Jernberg H., Nilsson K., Zech L., Lutz D., Nowotny H., Scheirer W. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996). Blood 1987, 69:1605.
25. Kardava L., Moir S., Shah N., Wang W., Wilson R., Buckner C.M., Santich B.H., Kim L.J., Spurlin E.E., Nelson A.K., Wheatley A.K., Harvey C.J., McDermott A.B., Wucherpfennig K.W., Chun T.W., Tsang J.S., Li Y., Fauci A.S. Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals. J. Clin. Invest. 2014, 124:3252.
26. Kasturi S.P., Skountzou I., Albrecht R.A., Koutsonanos D., Hua T., Nakaya H.I., Ravindran R., Stewart S., Alam M., Kwissa M., Villinger F., Murthy N., Steel J., Jacob J., Hogan R.J., Garcia-Sastre A., Compans R., Pulendran B. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011, 470:543.
27. Koup R.A., Douek D.C. Vaccine design for CD8 T lymphocyte responses. Cold Spring Harb. Perspect. Med. 2011, 1:a007252.
28. Lee F.E., Falsey A.R., Halliley J.L., Sanz I., Walsh E.E. Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. J. Infect. Dis. 2010, 202:1659.
29. Lee F.E., Halliley J.L., Walsh E.E., Moscatiello A.P., Kmush B.L., Falsey A.R., Randall T.D., Kaminiski D.A., Miller R.K., Sanz I. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J. Immunol. 2011, 186:5514.
30. Li G.M., Chiu C., Wrammert J., McCausland M., Andrews S.F., Zheng N.Y., Lee J.H., Huang M., Qu X., Edupuganti S., Mulligan M., Das S.R., Yewdell J.W., Mehta A.K., Wilson P.C., Ahmed R. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9047.
31. Liao H.X., Chen X., Munshaw S., Zhang R., Marshall D.J., Vandergrift N., Whitesides J.F., Lu X., Yu J.S., Hwang K.K., Gao F., Markowitz M., Heath S.L., Bar K.J., Goepfert P.A., Montefiori D.C., Shaw G.C., Alam S.M., Margolis D.M., Denny T.N., Boyd S.D., Marshal E., Egholm M., Simen B.B., Hanczaruk B., Fire A.Z., Voss G., Kelsoe G., Tomaras G.D., Moody M.A., Kepler T.B., Haynes B.F. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J. Exp. Med. 2011, 208:2237.
32. Liao H.X., Lynch R., Zhou T., Gao F., Alam S.M., Boyd S.D., Fire A.Z., Roskin K.M., Schramm C.A., Zhang Z., Zhu J., Shapiro L., Mullikin J.C., Gnanakaran S., Hraber P., Wiehe K., Kelsoe G., Yang G., Xia S.M., Montefiori D.C., Parks R., Lloyd K.E., Scearce R.M., Soderberg K.A., Cohen M., Kamanga G., Louder M.K., Tran L.M., Chen Y., Cai F., Chen S., Moquin S., Du X., Joyce M.G., Srivatsan S., Zhang B., Zheng A., Shaw G.M., Hahn B.H., Kepler T.B., Korber B.T., Kwong P.D., Mascola J.R., Haynes B.F. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 2013, 496:469.
33. Ling B., Rogers L., Johnson A.M., Piatak M., Lifson J., Veazey R.S. Effect of combination antiretroviral therapy on Chinese rhesus macaques of simian immunodeficiency virus infection. AIDS Res. Hum. Retrovir. 2013, 29:1465.
34. Medina F., Segundo C., Campos-Caro A., Gonzalez-Garcia I., Brieva J.A. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002, 99:2154.
35. Mei H.E., Yoshida T., Sime W., Hiepe F., Thiele K., Manz R.A., Radbruch A., Dorner T. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009, 113:2461.
36. Nakamura G., Chai N., Park S., Chiang N., Lin Z., Chiu H., Fong R., Yan D., Kim J., Zhang J., Lee W.P., Estevez A., Coons M., Xu M., Lupardus P., Balazs M., Swem L.R. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell Host Microbe 2013, 14:93.
37. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., Means A.R., Kasturi S.P., Khan N., Li G.M., McCausland M., Kanchan V., Kokko K.E., Li S., Elbein R., Mehta A.K., Aderem A., Subbarao K., Ahmed R., Pulendran B. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 2011, 12:786.
38. O'Connell F.P., Pinkus J.L., Pinkus G.S. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am. J. Clin. Pathol. 2004, 121:254.
39. Pelletier N., McHeyzer-Williams L.J., Wong K.A., Urich E., Fazilleau N., McHeyzer-Williams M.G. Plasma cells negatively regulate the follicular helper T cell program. Nat. Immunol. 2010, 11:1110.
40. Qian Y., Wei C., Eun-Hyung Lee F., Campbell J., Halliley J., Lee J.A., Cai J., Kong Y.M., Sadat E., Thomson E., Dunn P., Seegmiller A.C., Karandikar N.J., Tipton C.M., Mosmann T., Sanz I., Scheuermann R.H. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin. Cytom. 2010, 78(Suppl. 1):S69.
41. Rahman A., Rashu R., Bhuiyan T.R., Chowdhury F., Khan A.I., Islam K., LaRocque R.C., Ryan E.T., Wrammert J., Calderwood S.B., Qadri F., Harris J.B. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin. Vaccine Immunol. 2013, 20:1592.
42. Rawstron A.C., Fenton J.A., Ashcroft J., English A., Jones R.A., Richards S.J., Pratt G., Owen R., Davies F.E., Child J.A., Jack A.S., Morgan G. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood 2000, 96:3880.
43. Roederer M., Keele B.F., Schmidt S.D., Mason R.D., Welles H.C., Fischer W., Labranche C., Foulds K.E., Louder M.K., Yang Z.Y., Todd J.P., Buzby A.P., Mach L.V., Shen L., Seaton K.E., Ward B.M., Bailer R.T., Gottardo R., Gu W., Ferrari G., Alam S.M., Denny T.N., Montefiori D.C., Tomaras G.D., Korber B.T., Nason M.C., Seder R.A., Koup R.A., Letvin N.L., Rao S.S., Nabel G.J., Mascola J.R. Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. Nature 2014, 505:502.
44. Sanderson R.D., Lalor P., Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1989, 1:27.
45. Scheid J.F., Mouquet H., Feldhahn N., Seaman M.S., Velinzon K., Pietzsch J., Ott R.G., Anthony R.M., Zebroski H., Hurley A., Phogat A., Chakrabarti B., Li Y., Connors M., Pereyra F., Walker B.D., Wardemann H., Ho D., Wyatt R.T., Mascola J.R., Ravetch J.V., Nussenzweig M.C. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009, 458:636.
46. Scheid J.F., Mouquet H., Feldhahn N., Walker B.D., Pereyra F., Cutrell E., Seaman M.S., Mascola J.R., Wyatt R.T., Wardemann H., Nussenzweig M.C. A method for identification of HIV gp140 binding memory B cells in human blood. J. Immunol. Methods 2009, 343:65.
47. Shingai M., Nishimura Y., Klein F., Mouquet H., Donau O.K., Plishka R., Buckler-White A., Seaman M., Piatak M., Lifson J.D., Dimitrov D.S., Nussenzweig M.C., Martin M.A. Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia. Nature 2013, 503:277.
48. Smith K., Garman L., Wrammert J., Zheng N.Y., Capra J.D., Ahmed R., Wilson P.C. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 2009, 4:372.
49. Souto-Carneiro M.M., Longo N.S., Russ D.E., Sun H.W., Lipsky P.E. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J. Immunol. 2004, 172:6790.
50. Sundling C., Forsell M.N., O'Dell S., Feng Y., Chakrabarti B., Rao S.S., Lore K., Mascola J.R., Wyatt R.T., Douagi I., Karlsson Hedestam G.B. Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates. J. Exp. Med. 2010, 207:2003.
51. Sundling C., Phad G., Douagi I., Navis M., Karlsson Hedestam G.B. Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells. J. Immunol. Methods 2012, 386:85.
52. Sundling C., Li Y., Huynh N., Poulsen C., Wilson R., O'Dell S., Feng Y., Mascola J.R., Wyatt R.T., Karlsson Hedestam G.B. High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site. Sci. Transl. Med. 2012, 4:142ra96.
53. Sundling C., Zhang Z., Phad G.E., Sheng Z., Wang Y., Mascola J.R., Li Y., Wyatt R.T., Shapiro L., Karlsson Hedestam G.B. Single-cell and deep sequencing of IgG-switched macaque B cells reveal a diverse Ig repertoire following immunization. J. Immunol. 2014, 192:3637.
54. Szyszko E.A., Brun J.G., Skarstein K., Peck A.B., Jonsson R., Brokstad K.A. Phenotypic diversity of peripheral blood plasma cells in primary Sjogren's syndrome. Scand. J. Immunol. 2011, 73:18.
55. Tarte K., Zhan F., De Vos J., Klein B., Shaughnessy J. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood 2003, 102:592.
56. Tiller T., Meffre E., Yurasov S., Tsuiji M., Nussenzweig M.C., Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 2008, 329:112.
57. Walker L.M., Phogat S.K., Chan-Hui P.Y., Wagner D., Phung P., Goss J.L., Wrin T., Simek M.D., Fling S., Mitcham J.L., Lehrman J.K., Priddy F.H., Olsen O.A., Frey S.M., Hammond P.W., Kaminsky S., Zamb T., Moyle M., Koff W.C., Poignard P., Burton D.R. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009, 326:285.
58. Walker L.M., Huber M., Doores K.J., Falkowska E., Pejchal R., Julien J.P., Wang S.K., Ramos A., Chan-Hui P.Y., Moyle M., Mitcham J.L., Hammond P.W., Olsen O.A., Phung P., Fling S., Wong C.H., Phogat S., Wrin T., Simek M.D., Koff W.C., Wilson I.A., Burton D.R., Poignard P. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 2011, 477:466.
59. West A.P., Scharf L., Scheid J.F., Klein F., Bjorkman P.J., Nussenzweig M.C. Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 2014, 156:633.
60. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667.
61. Wrammert J., Koutsonanos D., Li G.M., Edupuganti S., Sui J., Morrissey M., McCausland M., Skountzou I., Hornig M., Lipkin W.I., Mehta A., Razavi B., Del Rio C., Zheng N.Y., Lee J.H., Huang M., Ali Z., Kaur K., Andrews S., Amara R.R., Wang Y., Das S.R., O'Donnell C.D., Yewdell J.W., Subbarao K., Marasco W.A., Mulligan M.J., Compans R., Ahmed R., Wilson P.C. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011, 208:181.
62. Wrammert J., Onlamoon N., Akondy R.S., Perng G.C., Polsrila K., Chandele A., Kwissa M., Pulendran B., Wilson P.C., Wittawatmongkol O., Yoksan S., Angkasekwinai N., Pattanapanyasat K., Chokephaibulkit K., Ahmed R. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J. Virol. 2012, 86:2911.
63. Xu M., Hadinoto V., Appanna R., Joensson K., Toh Y.X., Balakrishnan T., Ong S.H., Warter L., Leo Y.S., Wang C.I., Fink K. Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes. J. Immunol. 2012, 189:5877.
64. Zhou Y., Bao R., Haigwood N.L., Persidsky Y., Ho W.Z. SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans. Retrovirology 2013, 10:89.
65. Zucchetto A., Vaisitti T., Benedetti D., Tissino E., Bertagnolo V., Rossi D., Bomben R., Dal Bo M., Del Principe M.I., Gorgone A., Pozzato G., Gaidano G., Del Poeta G., Malavasi F., Deaglio S., Gattei V. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. Leukemia 2012, 26:1301.